Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer

Vergote, I., Trope, C. G., Amant, F., Ehlen, T., Reed, N.S. and Casado, A. (2011) Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer. Journal of Clinical Oncology, 29(31), pp. 4076-4078. (doi: 10.1200/JCO.2011.36.9785)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1200/JCO.2011.36.9785


Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Reed, Dr Nicholas
Authors: Vergote, I., Trope, C. G., Amant, F., Ehlen, T., Reed, N.S., and Casado, A.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Journal of Clinical Oncology
ISSN:0732-183X

University Staff: Request a correction | Enlighten Editors: Update this record